Summary:

Click image to enlarge
A randomized double-blind placebo controlled parallel group study to assess the efficacy, safety and tolerability of dexpramipexole administered orally for 52 weeks in participants with severe eosinophilic asthma
Qualified Participants Must:
18 years or older
Asthma Diagnosis for 12 months or greater, taking daily inhaled medication for asthma
Qualified Participants May Receive:
$125 for each visit for travel expense